Pallas Capital Advisors LLC Acquires 37,306 Shares of DENTSPLY SIRONA Inc. $XRAY

Key Points

• Pallas Capital Advisors LLC increased its stake in DENTSPLY SIRONA by 83.2%, acquiring an additional 37,306 shares to reach a total of 82,171 shares valued at approximately $1.3 million.
• DENTSPLY SIRONA reported earnings of $0.52 per share for the quarter, surpassing analysts' expectations of $0.50, although revenue was down 4.9% year-over-year.
• The company announced a quarterly dividend of $0.16 per share to be paid on October 10th, indicating a yield of 4.8% based on annualized payouts.

Pallas Capital Advisors LLC increased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 83.2% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,171 shares of the medical instruments supplier's stock after purchasing an additional 37,306 shares during the period. Pallas Capital Advisors LLC's holdings in DENTSPLY SIRONA were worth $1,305,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Krilogy Financial LLC purchased a new stake in DENTSPLY SIRONA in the 2nd quarter valued at about $336,000. MassMutual Private Wealth & Trust FSB boosted its stake in DENTSPLY SIRONA by 160.2% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 2,805 shares of the medical instruments supplier's stock worth $45,000 after buying an additional 1,727 shares during the last quarter. Parallel Advisors LLC raised its holdings in shares of DENTSPLY SIRONA by 142.4% during the 2nd quarter. Parallel Advisors LLC now owns 14,910 shares of the medical instruments supplier's stock valued at $237,000 after buying an additional 8,760 shares during the period. First Community Trust NA increased its holdings in DENTSPLY SIRONA by 66.0% during the 2nd quarter. First Community Trust NA now owns 15,090 shares of the medical instruments supplier's stock worth $240,000 after purchasing an additional 6,000 shares during the last quarter. Finally, Kera Capital Partners Inc. acquired a new position in DENTSPLY SIRONA during the 2nd quarter valued at approximately $170,000. Institutional investors and hedge funds own 95.70% of the company's stock.

Analysts Set New Price Targets

XRAY has been the topic of a number of research analyst reports. Stifel Nicolaus lowered their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research report on Friday, August 8th. Wall Street Zen lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Barrington Research lowered their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a research report on Friday, August 8th. UBS Group decreased their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Finally, Wells Fargo & Company cut their target price on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research note on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $18.64.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY traded down $0.26 during trading hours on Friday, hitting $13.16. The stock had a trading volume of 6,019,803 shares, compared to its average volume of 2,626,561. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The firm has a market capitalization of $2.63 billion, a price-to-earnings ratio of -2.78, a P/E/G ratio of 0.84 and a beta of 0.96. The company has a 50 day simple moving average of $14.44 and a two-hundred day simple moving average of $14.93. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $27.44.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. During the same period in the prior year, the firm posted $0.49 earnings per share. The company's quarterly revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.9%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -13.50%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.